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Changes in gene expression contribute to the long-
lasting regulation of the brain’s reward circuitry
seen in drug addiction; however, the specific genes
regulated and the transcriptional mechanisms un-
derlying such regulation remain poorly unders-
tood. Here, we used chromatin immunoprecipitation
coupled with promoter microarray analysis to charac-
terize genome-wide chromatin changes in the mouse
nucleus accumbens, a crucial brain reward region,
after repeated cocaine administration. Our findings
reveal several interesting principles of gene regula-
tion by cocaine and of the role of DFosB and
CREB, two prominent cocaine-induced transcription
factors, in this brain region. The findings also provide
comprehensive insight into the molecular pathways
regulated by cocaine—including a new role for
sirtuins (Sirt1 and Sirt2)—which are induced in the
nucleus accumbens by cocaine and, in turn, dramat-
ically enhance the behavioral effects of the drug.
INTRODUCTION
Repeated use of addictive drugs such as cocaine causes long-
lasting changes in the brain’s reward circuitry, a key component
of which is the nucleus accumbens (NAc). Accordingly, a major
goal in the field has been to uncover the molecular mechanisms
underlying addiction-associated neuroadaptations in this brain
region. It has been hypothesized that one such mechanism is
the regulation of gene expression (Hyman et al., 2006), and there
have been numerous studies that have documented altered
expression of genes, through candidate gene approaches or
through gene expression arrays, in the NAc (Freeman et al.,
2001; McClung and Nestler, 2003; Yao et al., 2004). As well,
several transcription factors have been shown to be altered
in the NAc after chronic cocaine exposure, including DFosB(a Fos family protein; Hiroi et al., 1997; Nestler, 2008) and
CREB (cAMP response element binding protein; Carlezon
et al., 2005), which have both been related directly to the behav-
ioral abnormalities that characterize an addicted state.
DFosB is induced uniquely by chronic cocaine exposure and
persists for several weeks after drug cessation due to the
unusual stability of the protein (Nestler, 2008). Increasing
evidence supports the view that this induction of DFosB
increases rewarding responses to, and incentive motivation
for, cocaine (Colby et al., 2003; Hiroi et al., 1997; Kelz et al.,
1999; McClung and Nestler, 2003; Nestler, 2008). In contrast,
CREB activity is induced in response to acute or chronic cocaine
administration and serves a homeostatic role by reducing sensi-
tivity to drug reward and mediating negative emotional symp-
toms during drug withdrawal (Carlezon et al., 2005).
However, all investigations of cocaine-induced changes in
gene expression to date have focused by necessity on measures
of steady-state mRNA levels, which may not always reflect the
transcriptional regulation of the encoding genes. Recent
advances in chromatin biology have made it possible for the first
time to extend this level of knowledge to direct examination of
transcriptional mechanisms. Thus, we now know, largely from
studies of nonneural tissue, that the state of activation or repres-
sion of a gene is typically reflected in the covalent modifications
of histone proteins in the gene’s vicinity (Kouzarides, 2007). The
vast majority of reports indicate that increased acetylation of
histone H3 or H4 is highly predictive of gene activation, while
increased methylation of H3 at K9 or K27 (Lys9 or 27) is predic-
tive of gene repression. Chromatin immunoprecipitation (ChIP),
where tissue is lightly fixed to crosslink DNA with histones and
other DNA-binding proteins and then immunoprecipitated for
a protein of interest (e.g., acetylated H3), can be used to assess
the extent to which a given gene is associated with these
markers of activation or repression. For example, we recently
demonstrated by use of ChIP that chronic administration of
cocaine or related psychostimulants increases or decreases
histone acetylation in the NAc at the promoters of several genes
whose mRNA levels are known to be increased or decreased,
respectively, by the drug. Moreover, we directly implicated
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for this transcription factor under these conditions (Kumar
et al., 2005; Renthal et al., 2008).
ChIP represents a powerful advance in establishing regulation
of gene transcription by cocaine, but traditional methods are still
limited by the analysis of individual genes of interest one at
a time. Moreover, regulation of a gene may be mediated by
many types of coincident alterations of histones and related
modifications (Kouzarides, 2007). These considerations argue
for the importance of analyzing the immunoprecipitated DNA,
not for an individual gene, but genome-wide using ChIP-chip
assays, to gain a global view of genes that show markers of
activation or repression after cocaine. In the present study, we
mapped the genomic effects of chronic cocaine in the NAc by
performing ChIP-chip for acetylated and methylated histones
and for DFosB and phospho-CREB (the activated form of this
transcription factor). We then demonstrate that one family of
target genes, the sirtuins, discovered by ChIP-chip to be regu-
lated in the NAc by chronic cocaine, contributes directly to
addiction-related behaviors. These findings provide fundamen-
tally new insight into cocaine’s regulation of gene transcription
in this brain reward region.
RESULTS
Cocaine Regulation of Histone Acetylation
and Methylation in the NAc
To extend our previous ChIP studies (see Renthal and Nestler,
2008), which identified that cocaine or amphetamine administra-
tion alters histone acetylation and methylation at specific genes
in the NAc, we mapped the genome-wide promoter binding of
these histone modifications in the NAc from mice treated chron-
ically with cocaine (20 mg/kg/day for 7 days, i.p.) or saline. To do
this, we performed ChIP with antibodies directed against polya-
cetylated H3 (K9 and K14), polyacetylated H4 (K5, K8, K12, and
K16), or dimethylated H3 (K9 and K27) on independent pools of
NAc lysates, with each pooled sample representing bilateral NAc
dissections from eight mice. These histone modifications have
been widely shown to reflect the state of gene activation or
repression (Kouzarides, 2007). The immunoprecipitated DNA,
as well as input (total) DNA, was sheared and then repaired,
amplified, and labeled with a fluorescent dye with the use of liga-
tion-mediated PCR (Sikder et al., 2006). Cy5-labeled immuno-
precipitated DNA and Cy3-labeled total DNA were mixed and
hybridized to NimbleGen promoter microarrays (Madison, WI),
which span the promoters of 20,000 genes. After preprocess-
ing, normalization, and identification of binding sites using
Mpeak, statistical analysis of cocaine-induced changes in
promoter occupancy was performed. Since the distribution of
fold changes was slightly short-tailed, we performed a nonpara-
metric analysis using 3.1 standard deviations as a cutoff, which
would roughly correspond to p < 0.001 under normal assump-
tions (see Supplemental Experimental Procedures available
online). These unique datasets provided a view of cocaine-regu-
lated gene targets and the regulatory mechanisms in this critical
brain reward region.
Repeated cocaine administration induced hyperacetylation of
histone H3 at 1004 gene promoters in NAc and hypoacetylation336 Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc.at 83 gene promoters compared to saline-treated controls (Fig-
ure 1A). Similarly, chronic cocaine caused hyperacetylation of
histone H4 at 692 gene promoters and hyopacetylation at 123.
It is interesting to note that several fold more genes showed
H3 or H4 hyperacetylation after chronic cocaine compared to
hypoacetylation. This is consistent with our earlier findings,
from DNA expression arrays, that the predominant effect of
cocaine is gene activation (McClung and Nestler, 2003; Renthal
et al., 2007), and with more recent findings that reductions in
histone acetylation block cocaine’s behavioral effects while
increases in acetylation augment cocaine action (Kumar et al.,
2005; Renthal et al., 2007). A striking finding from the present
study is that only about 15% of regulated gene promoters
showed increased acetylation of both H3 and H4 (see Figure 1A).
Even less overlap was observed with genes hypoacetylated at
H3 and H4 (1%). While these overlaps are statistically significant,
the very small amount of overlap suggests that acetylation of one
histone is sufficient to induce transcription in the NAc in vivo,
consistent with cell culture data (Kurdistani et al., 2004; McCool
et al., 2007). Moreover, it suggests that cocaine-induced
signaling in the NAc converges on at least two mechanistically
distinct pathways for histone acetylation of H3 versus H4, which
overlap sparsely. Cocaine-induced changes in H3 acetylation
occurred at a larger number of genes than H4 acetylation,
consistent with our earlier demonstration that chronic cocaine
induces selective H3 acetylation at several candidate gene
targets (FosB, Cdk5 [cyclin-dependent kinase 5], Bdnf [brain-
derived neurotrophic factor]), with no induction of H4 acetylation
observed (Kumar et al., 2005). However, we did observe
increased H4 acetylation at several hundred gene promoters
after chronic cocaine in the present study, which underscores
the importance of this genome-wide investigation.
Numerous genes, shown in previous studies to be upregulated
in NAc after chronic cocaine, were found in our ChIP-chip data to
be associated with hyperacetylation of H3 or H4. Examples of
such genes are listed in Table 1 (see Tables S1–S3 for complete
gene lists). Importantly, many of these individual genes have
been directly related to aspects of neural and behavioral plas-
ticity associated with cocaine exposure (see below). These
observations provide important validation for our ChIP-chip
approach and highlight the potential significance of the >1000
other genes that show similar markers of activation in this study.
To experimentally determine the quality of our new ChIP-chip
data sets, we performed quantitative ChIP on independent
cohorts of saline and cocaine-treated mice. Analysis of 20
randomly selected target genes revealed that our ChIP-chip
data have a false-positive rate of 25%—15 out of 20 genes
demonstrated statistically significant cocaine-induced changes
in histone acetylation and three additional genes showed
nonsignificant trends (see Supplemental Data). These findings
demonstrate that our new gene lists are of excellent quality,
especially given that they are derived from in vivo tissue samples
of adult brain.
The genome-wide acetylation patterns of H3 and H4 show
interesting features similar to previous reports in cell culture (Li
et al., 2007; Figure S1). Levels of acetylated H3 and H4 were
maximal between 500 to +200 bp, with acetylated H3 forming
a bimodal peak and acetylated H4 forming a single peak over
Neuron
Genome-wide Chromatin Regulation by Cocainetranscription start sites. Notably, these overall patterns were not
significantly altered by chronic cocaine administration, indi-
cating that, on average, cocaine increases the amount of acety-
lation on specific promoters (Figure 1A) rather than altering the
spatial distribution of acetylation within promoters (Figure S1).
Representative examples of cocaine-regulated gene promoters
illustrate both prototypical and less common patterns of H3
and H4 acetylation (Figure 1B). The gene encoding CART
(cocaine- and amphetamine-regulated transcript) showed signif-
A
B
Figure 1. Regulation of Histone Acetylation
and Methylation at Gene Promoters in the
NAc by Chronic Cocaine
(A) Venn diagrams of genes that show altered
levels of H3 or H4 acetylation and H3 methylation
(dimethyl-K9/K27) binding 24 hr after chronic
(7 days) cocaine administration.
(B) Patterns of cocaine-induced changes in H3 and
H4 acetylation and H3 methylation at 6 representa-
tive gene promoters previously implicated in
cocaine action.
icant hyperacetylation of both H3 and H4
at an overlapping region of its promoter,
each of which was very similar to the
genome-wide average shown in Fig-
ure S1. Two other genes that are upregu-
lated by cocaine (Fosnaugh et al., 1995;
Sivam, 1989) and display acetylation
patterns similar to the genome-wide
average are Arc (activity regulated cyto-
skeletal-associated protein) and Pdyn
(prodynorphin). Distinct from CART,
however, the upregulation of ARC and
PDYN by cocaine are associated with
significant acetylation of a single histone
only, H3 or H4, respectively. Per1 (period
1, a circadian gene) is also upregulated by
cocaine (McClung and Nestler, 2003) and
is only hyperacetylated significantly on
H4, but it displays a pattern of acetylation
distinct from the genome-wide average.
While the acetylation peak closest to the
transcription start site overlaps with the
region of DFosB binding (Table 1 and
data not shown), the significance of the
more upstream peak is unknown and
may represent a region of regulatory
elements. However, most of the genes
regulated by cocaine show only one
peak of altered acetylation, suggesting
a single regulatory region important for
its cocaine-induced activity. Another
illustrative gene is Cdk5, which shows
selective hyperacetylation of H3 that
correlates with cocaine-induced upregu-
lation of its transcription (Bibb et al.,
2001). Moreover, the selective increase
in acetylated H3 at the Cdk5 promoter after chronic cocaine is
consistent with our previous findings using quantitative ChIP
(Kumar et al., 2005) and further supports the quality of our
genome-wide study. In addition to the genes highlighted here,
we identified numerous other cocaine-regulated genes that
display significant alterations in histone acetylation on their
promoters (see Table 1). Examples include Adcy3 (adenylyl
cyclase 3), Adora1 (adenosine receptor A1), Drd3 (dopamine
receptor D3), and Rgs9 (regulator of G protein signaling 9).Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc. 337
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Genome-wide Chromatin Regulation by CocaineTable 1. Examples of Genes that Show Chromatin Regulation by Chronic CocaineEach of these genes has been implicated in cocaine action in the
NAc (see Supplemental References for Table 1 in Supplemental
Data). Taken together, a clear pattern emerges from these find-
ings (Figure 1, Table 1, and Tables S1–S3): cocaine-induced
increases in acetylation of either H3 or H4 correlates strongly
with elevated gene expression in the NAc in vivo and reveals
numerous genes implicated in cocaine action.338 Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc.Methylation of H3 at K9 and K27 in promoter regions is
involved not only in silencing heterochromatin but has also
been shown to repress genes in transcriptionally active euchro-
matin (Kouzarides, 2007). It was, therefore, of interest to charac-
terize this marker of gene repression in NAc after chronic
cocaine. We focused on dimethyl-K9/K27, because preliminary
ChIP experiments revealed that these modifications were the
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tage of this analysis is that it provides a look at genes that are
largely repressed or silenced by cocaine, a relatively underex-
plored adaptation.
We found that chronic cocaine reduced levels of H3 dimethyl-
K9/K27 at the promoter regions of 209 genes while increasing it
at 898 genes in the NAc compared to saline-treated controls
(Figure 1A; see Table S4). Interestingly, the genome-wide distri-
bution of this methylation mark occurred on a much broader
promoter span (from 1600 to +500 bp) compared to that
observed for histone acetylation (Figure S1), similar to the
pattern of histone methylation observed in cultured cell lines
and yeast (Li et al., 2007). Although the genome-wide distribution
did not change after chronic cocaine exposure, cocaine
increased histone methylation levels at several-fold more genes
than it decreased. This finding suggests that cocaine represses
the expression or dampens the induction of many genes, despite
the predominant effect of cocaine being gene activation
(McClung and Nestler, 2003). Moreover, just as few genes
showed significant changes in acetylation of both H3 and H4,
there was minimal (2%) overlap between genes that showed
reduced histone acetylation and those that showed increased
H3 methylation after chronic cocaine (see Figure 1A and Table
S5). These findings suggest that, for the vast majority of
cocaine-regulated gene promoters in the NAc, activation or
repression involves independent alterations in histone acetyla-
tion or methylation.
Moreover, relatively few cocaine-regulated genes were asso-
ciated with reductions of histone acetylation or methylation, sug-
gesting that the most common mechanisms of cocaine-induced
gene regulation in the NAc involve increases in histone acetyla-
tion for gene activation (rather than demethylation) or histone
methylation for gene repression (rather than deacetylation). For
example, the gene encoding the K+ channel subunit, KCNV2,
which is downregulated by cocaine (Renthal et al., 2007),
showed increased H3 dimethyl-K9/K27 at its promoter without
a change in histone acetylation, while PDYN and ARC, which
are upregulated by cocaine (Fosnaugh et al., 1995; McClung
and Nestler, 2003; Sivam, 1989), showed increased acetylation
on their promoters without any changes in methylation (see
Figure 1B). Although increases in acetylation or methylation
predominate, a subset of genes show reduced H3 acetylation
or methylation after chronic cocaine exposure (e.g., the genes
encoding semaphorin 5b and adenosine deaminase). Thus,
hypoacetylation and hypomethylation may play an important
role in gene regulation at a smaller subset of genes in response
to chronic cocaine exposure.
Role of DFosB in the Genomic Effects of Cocaine
in the NAc
DFosB has been shown to play an important role in addiction: its
overexpression in the NAc increases an animal’s responses to
the rewarding effects of cocaine and of morphine, while overex-
pression of a dominant-negative antagonist, termed DcJun,
causes the opposite effects (Nestler, 2008). A previous gene
expression array study identified genes in the NAc whose
expression is altered upon overexpression of DFosB or DcJun
(McClung and Nestler, 2003). However, this study could notprovide information as to which of these genes are direct targets
for DFosB or regulated indirectly via other mechanisms. To
address this question, we carried out ChIP for DFosB in mice
treated with chronic cocaine or saline. Since a change in the
absolute level of a transcription factor on a given promoter is
not necessarily an indication of its activity, we simply identified
the gene promoters significantly occupied by DFosB under
saline and cocaine-treated conditions independently. After
preprocessing and normalization, we generated a high-confi-
dence gene list at a false discovery rate of 5% using established
methodology (see Supplemental Experimental Procedures). In
chronic cocaine-treated mice, DFosB was bound to nearly
40% more promoters (1553) than it was in saline-treated mice
(1113) (see Tables S6 and S7), which is consistent with the
several fold induction of DFosB in the NAc by cocaine (Nestler,
2008).
To determine how DFosB binding affects the expression of
its target genes in the NAc after chronic cocaine exposure, we
identified which DFosB gene targets also showed significant
cocaine-induced changes in chromatin markers of gene activa-
tion or repression (see Table S8). Roughly 13% of the significant
DFosB gene targets in cocaine-treated mice exhibited coinci-
dent increases in histone acetylation, which suggests that
DFosB may be acting as a transcriptional activator at these
genes (Figure 2A; Table S8). DFosB is also known to act as a
transcriptional repressor at certain genes, and while very few
DFosB-bound genes showed hypoacetylation 24 hr after chronic
cocaine (Figure S2), roughly 8% of DFosB targets showed
increased histone H3K9/27 methylation (Figure 2A). These genes
may represent targets where DFosB acts as a repressor.
While statistical analysis did not reveal a significant interaction
between DFosB binding and histone acetylation or methylation
on a global scale, the overlapping gene lists may represent the
specific targets whereDFosB affects gene expression 24 hr after
the last dose of cocaine. Since we only analyzed DFosB binding
24 hr after the final cocaine dose,DFosB may promote chromatin
and transcriptional changes at many additional gene promoters
with different kinetics.
The large majority of DFosB-bound genes identified here
appear to be bona fide targets, since levels of their mRNA’s
are significantly regulated after inducible overexpression of
DFosB or its dominant-negative DcJun in the NAc (Figure 2C),
which provides important validation of our ChIP-chip data. Inter-
estingly, increased binding of DFosB to gene promoters is asso-
ciated with either increased or decreased mRNA expression,
consistent with its complex role as both a transcriptional acti-
vator and repressor depending on the gene in question (McClung
and Nestler, 2003; Renthal et al., 2008).
DFosB displayed significant binding to a broad region of
promoters genome-wide (1500 to +250 bp) (Figure S1), similar
to that of H3 dimethyl-K9/K27. As with histone acetylation and
methylation, chronic cocaine did not significantly affect the
average position of the genome-wide pattern of DFosB binding.
DFosB was found to be strongly enriched on many genes previ-
ously implicated in behavioral responses to cocaine, as well as
others that now warrant further investigation. Figure 2B illus-
trates DFosB binding across the promoters of four representa-
tive genes after chronic cocaine. For each promoter, the figureNeuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc. 339
Neuron
Genome-wide Chromatin Regulation by Cocaineshows where DFosB binding is enriched relative to the gene’s
transcription start site and the location of the nearest consensus
AP1 (activator protein 1) site (TGA[C/G]TCA) or near-consensus
site (1 bp different). One DFosB target gene,Gpsm1 (AGS3, acti-
vator of G protein signaling 3) is upregulated for weeks after
cocaine exposure in the NAc and has been shown to be critically
involved in behavioral responses to cocaine (Bowers et al.,
2004). The stability and persistence of DFosB during weeks of
drug withdrawal further support its role as a key regulator of
AGS3 transcription during this period. Examples of genes where
DFosB is associated with promoter hyperacetylation are Grin2a
(NMDAR2A subunit) (Hemby et al., 2005), Per1 (Period 1), and
Adora1 (Adenosine receptor A1) (Toda et al., 2002), each of
which is known to be upregulated after chronic cocaine expo-
sure and implicated in behavioral responses to cocaine (see
Table 1). Together, these data indicate that the induction of
DFosB in the NAc by cocaine regulates numerous gene targets,
A
B
C
Figure 2. Regulation of DFosB and Phos-
pho-CREB Binding at Gene Promoters in
the NAc by Chronic Cocaine
(A) Venn diagrams of genes that show significant
levels of DFosB or phospho-CREB binding, or of
H3/H4 acetylation or H3 methylation, after chronic
(7 days) cocaine.
(B) Patterns of DFosB (green) and phospho-CREB
(purple) binding at representative gene promoters
after chronic cocaine (solid line) or saline (dotted
line) treatment. Short bold lines on the x axes indi-
cate positions of consensus or near-consensus
AP1 (red) or CRE (orange) sites.
(C) The top panel illustrates significant DFosB
target genes from ChIP-chip (histogram) after
chronic cocaine exposure and how expression
of the encoded mRNAs are regulated upon induc-
ible overexpression (O.E.) of either DFosB or its
dominant-negative antagonist DcJun in the NAc
(heatmaps) (r = 0.09, p = 0.005). The bottom
panel illustrates significant phospho-CREB target
genes from ChIP-chip (histogram) after chronic
cocaine exposure and how expression of the
encoded mRNAs are regulated upon inducible
overexpression of either CREB or its dominant-
negative antagonist mCREB (heatmaps) in the
NAc (r = 0.3, p < 1E-16).
which now offer a much more complete
understanding of the complex mecha-
nisms by which this transcription factor
mediates sensitized drug reward.
Role of CREB in the Genomic
Effects of Cocaine in the NAc
As stated earlier, repeated cocaine
administration induces CREB activity
in the NAc, which then feeds back and
attenuates the rewarding effects of
cocaine (Carlezon et al., 2005). Cocaine
activates CREB by increasing its phos-
phorylation at Ser133. Phosphorylation
of CREB, which is often bound to responsive genes at CRE
(cAMP response element) sites even in the absence of its phos-
phorylation, contributes to the recruitment of transcriptional co-
activators such as the histone acetyltransferase, CBP (CREB
binding protein), to promote gene transcription (Mayr and Mont-
miny, 2001). Therefore, to gain insight into the transcriptional
actions of CREB in the NAc after chronic cocaine, we carried
out ChIP for phospho-CREB followed by promoter array assays.
These data were then analyzed as described above for DFosB,
by generating a high-confidence list of gene targets with a false
discovery rate of 5%. After chronic cocaine exposure, we found
that phospho-CREB was bound significantly to the promoters of
1743 genes, approximately 38% more genes than were occu-
pied in saline-treated mice (1259; Figure 2A; Tables S9 and
S10). Roughly 12% of the phospho-CREB-bound genes after
chronic cocaine exhibited cocaine-induced increases in histone
acetylation, a marker of gene activation (Figure 2A; Table S11),340 Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc.
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promotes transcription 24 hr after chronic cocaine exposure.
Interestingly, 10% of genes to which phospho-CREB is bound
exhibit coincident increases in H3 dimethyl-K9/K27, a marker of
repression, which suggests that phospho-CREB acts as a tran-
scriptional repressor at certain genes (Mayr and Montminy,
2001). The overlapping gene lists of significant phospho-CREB
binding and cocaine-induced changes in histone acetylation or
methylation may represent the most likely targets where phos-
pho-CREB alters gene activity 24 hr after the last dose of cocaine.
Among the genes that show significant phospho-CREB
binding after chronic cocaine are many that have previously
been implicated in cocaine and CREB action, such as Pdyn,
Fos (c-Fos), Nrgn (neurogranin), and Grin2A (Carlezon et al.,
1998; Hemby et al., 2005; McClung and Nestler, 2003; Zhang
et al., 2006), among other examples given in Figure 2B, Table 1,
and Table S9. For each gene promoter illustrated in Figure 2B,
the figure shows where phospho-CREB binding is enriched rela-
tive to the gene’s transcription start site and the location of the
nearest consensus CRE site (TGACGTCA) or near-consensus
site (1 bp different).
As observed for DFosB, many gene promoters (e.g., Ephb1,
Wnt7a, Mbd2) showed greater enrichment of phospho-CREB
binding in cocaine-treated mice versus saline-treated mice, which
is likely related to the increased levels of phospho-CREB present
in the NAc at this time point. Interestingly, however, this pattern
was not observed for all phospho-CREB targets (e.g., Pdyn,
c-Fos): these genes showed equivalent levels of phospho-CREB
binding under cocaine- and saline-treated conditions despite
higher levels of expression of these genes after cocaine. These
findings suggest that changes in gene activity can be coordinated
by recruitment of other cofactors, such as CBP (Levine et al., 2005;
Zhang et al., 2005), to a constant level of phospho-CREB on the
promoter.Moreover, on average, the genome-wide spatial pattern
of phospho-CREBbinding relative to gene transcription start sites,
which exhibits a relatively sharp peak between500 and +200 bp
and a weaker peak beyond500 bp up to1500 bp (Figure S1), is
not altered by chronic cocaine exposure.
To gain insight into how phospho-CREB binding after chronic
cocaine may alter gene activity, we compared our phospho-
CREB ChIP-chip data to gene expression data from mice over-
expressing CREB or its dominant-negative, mCREB, in the
NAc (McClung and Nestler, 2003). Importantly, inducible overex-
pression of mCREB in the NAc oppositely regulates most of the
gene expression changes observed after CREB overexpression
(Figure 2C). The high degree of overlap between phospho-CREB
binding and CREB-induced changes in gene expression
provides further confidence in our phospho-CREB ChIP-chip
data and suggests that most genes to which phospho-CREB is
bound after chronic cocaine are indeed bona fide CREB targets.
A notable feature of our prior gene expression analysis of
DFosB and CREB overexpression in the NAc (McClung and
Nestler, 2003) was the identification of a subset of genes regu-
lated by both transcription factors. Using ChIP-chip, we found
a significant 20% overlap between the cocaine-induced DFosB-
and phospho-CREB-bound genes (Figure S2; Table S12). The
20% overlap observed here is not as strong as that found in
our earlier overexpression study, but this may reflect a temporaldisconnect between transcription factor binding and changes in
steady-state mRNA levels (e.g., coactivators are not immediately
recruited) or indirect effects of CREB and DFosB overexpression
on gene regulation. Nevertheless, many of the 323 overlapping
genes, including the genes encoding AGS3, the D1 receptor,
the CCKA receptor (cholecystokinin A receptor), IkB3 (inhibitor
of kappaB), 5-HT2AR (serotonin 2A receptor), and the NMDA2A
receptor subunit (see Table S12 for complete list) have been
implicated previously in cocaine responses and likely contribute
to the potent action of these two transcription factors on
cocaine-induced behaviors (Carlezon et al., 2005; Nestler,
2008). The list of overlapping DFosB and CREB target genes
generated here offers a rich array of genes that influence cocaine
action at the level of the NAc.
Discovery of a Pathway Involved in Cocaine Action:
Studies of SIRT1 and SIRT2
Thus far, our discussion has highlighted examples of known
cocaine targets that show altered histone modifications orDFosB
or phospho-CREB binding in our ChIP-chip studies. However,
the arrays also provide rich lists of many genes, not heretofore
implicated in cocaine action, which show robust and highly signif-
icant markers of activation or repression in response to chronic
cocaine. It was, therefore, important to evaluate the predictive
power of these gene lists for revealing fundamentally new insight
into the molecular pathophysiology of cocaine action in the NAc.
One gene family was of particular interest: the sirtuins. Sirtuins—
also referred to as SIRT’s (silent information regulator of tran-
scription)—are categorized as Class III NAD-dependent histone
deacetylases, which in addition to deacetylating histones also
deacetylate other cellular proteins, such as tubulin, p53 (a tumor
suppressor transcription factor), and NFkB (nuclear factor kappa
B; Denu, 2005). Sirtuins are highly conserved from bacteria to
mammals—seven forms have been identified in mouse and
human—and have been implicated in diverse processes,
including cell morphology, growth, apoptosis, general metabo-
lism, and aging (Michan and Sinclair, 2007), although very little
is known about their function in the nervous system.
Our ChIP-chip studies identified significant enrichment of
DFosB on the Sirt2 promoter after chronic cocaine exposure,
indicating a potential role in cocaine responses (Figure 3A; Table
1). After analyzing the promoter of Sirt2 in more detail, we
noticed that there was also a strong increase in acetylated H3
downstream of the AP1/DFosB-binding site that we had over-
looked because it fell just below the 3.1 SD cutoff. In an indepen-
dent cohort of mice, we confirmed that chronic cocaine signifi-
cantly increases levels of DFosB and acetylated H3 on the
Sirt2 promoter (Figure 3B) and that this is associated with
increased Sirt2 mRNA expression in the NAc (Figure 3B). More-
over, we found significant cocaine-induced H3 acetylation of
a related sirtuin,Sirt1, in this brain region, a finding which we vali-
dated in an independent ChIP experiment and showed is asso-
ciated with a significant increase in Sirt1 mRNA levels (Figures
3A and 3B). To determine whether the increases observed in
histone acetylation, DFosB-binding, and transcription of Sirt1
and Sirt2 are associated with changes in functional protein, we
incubated cocaine-treated NAc lysates with a fluorescent
substrate of SIRT1 or SIRT2. Consistent with the ChIP-chip,Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc. 341
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cantly increases both SIRT1 and SIRT2 catalytic activity in the
NAc (Figure 3C). Acute exposure to cocaine does not alter
SIRT1 or SIRT2 activity, suggesting that the upregulation of sir-
tuins in NAc may contribute to the chronic neuroadaptations
involved in drug addiction. Together, these data illustrate the
predictive quality of our ChIP-chip analyses and suggest that
our stringent cutoff of 3.1 SD may even underestimate the
number of cocaine-regulated promoters.
The cocaine-induced upregulation of SIRT1 and SIRT2 in the
NAc prompted us to examine how these enzymes affect the
physiological activity of NAc neurons. To do this, we performed
whole-cell current-clamp recordings of medium spiny neurons
(MSNs) in acute NAc slices incubated with a pharmacological
inhibitor (sirtinol) or activator (resveratrol) of sirtuins. We found
that 30 mM sirtinol nearly silenced NAc neurons, reducing the
number of spikes elicited by 100 pA current injection by 90%
compared to vehicle (0.1% DMSO). Moreover, the minimum
amount of current needed to elicit an action potential (rheobase)
was significantly higher in sirtinol-treated slices (Figure 4A),
consistent with a decrease in NAc MSN excitability (Figure 4B).
Conversely, the sirtuin activator resveratrol (50 mM) potently
A
B
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Figure 3. Validation of Sirtuins as a Target
for Cocaine in the NAc
(A) Changes in histone H3 and H4 acetylation,
H3 K9/K27 methylation, and DFosB and phos-
pho-CREB binding at the Sirt1 and Sirt2 gene
promoters in the NAc after chronic (7 days)
cocaine. A short red bold line along the x axis
indicates the position of an AP1 site. Significant
changes are shown as solid lines.
(B) Quantitative ChIP confirmed cocaine-induced
increases in H3 acetylation at the Sirt1 (left) and
Sirt2 (right) gene promoters in an independent
cohort of mice (p < 0.05, n = 3–6). Cocaine-
induced DFosB binding was also confirmed for
the Sirt2 promoter (p < 0.05, n = 3–6). This chro-
matin regulation is associated with significant
increases in Sirt1 and Sirt2 (p < 0.05, n = 7–8)
mRNA levels in the NAc.
(C) As well, SIRT1 and SIRT2 catalytic activity
was significantly increased in NAc after chronic
cocaine administration (p < 0.05, n = 7–8).
Error bars indicate SEM.
increased NAc MSN excitability while
reducing rheobase, suggesting that
cocaine-induced increases in SIRT1 and
SIRT2 activity may be associated with
increased NAc excitability. Individual
traces are shown in Figure 4C, which
illustrate the dramatic effects of
inhibiting or activating sirtuins on the
functional activity of NAc MSN neurons.
We next tested directly whether
elevated sirtuin activity in the NAc is
involved in behavioral responses to
cocaine. To do this, we used resveratrol
and sirtinol in the conditioned place pref-
erence assay, where animals learn to prefer a cocaine-paired
environment. We administered resveratrol systemically since
this drug is known to penetrate the brain after systemic adminis-
tration (Baur and Sinclair, 2006), and sirtinol directly into the NAc
using an osmotic minipump connected to guide cannulae.
Similar to our electrophysiological observations, resveratrol
and sirtinol exerted opposite effects on cocaine reward, with re-
sveratrol significantly enhancing cocaine place conditioning and
sirtinol significantly attenuating it (Figures 5A and 5B).
While these data directly implicate sirtuins in regulating the
rewarding effects of cocaine, cocaine addiction is marked by moti-
vation to take drug, which isbestassayed in the self-administration
paradigm. Thus, we delivered sirtinol or vehicle via osmotic mini-
pump directly into the NAc of rats, which were subsequently
trained to self-administer cocaine. Sirtinol had no effect on the
acquisition phase of cocaine self-administration (data not shown).
However, while vehicle-infused rats displayed normal cocaine-
seeking behavior throughout the ascending and descending limbs
of the cocaine dose-response curve, sirtinol-infused ratsdisplayed
a dramatic reduction incocaine self-administration (Figure5C).Sir-
tinol did not affect responding on the inactive nose poke aperture,
which provides an important control for the lack of effect of sirtinol342 Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc.
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of NAc Neurons
(A) Incubation (20 min) of acute NAc slices from adult mice with
the sirtuin inhibitor, sirtinol (30 mM), caused a significantly
higher rheobase compared to control (DMSO-treated) slices
(ANOVA: F (2,13) = 24.64, p < 0.0001, Tukey’s post hoc
compared to DMSO, *p < 0.05). Conversely, slices incubated
with 50 mM resveratrol, a sirtuin activator, exhibited a signifi-
cant reduction in rheobase (*p < 0.05).
(B) A 100 pA injection into NAc neurons incubated with sirtinol
(30 mM) elicits significantly fewer action potentials compared
to control, while incubation with resveratrol (50 mM) results in
significantly more firing than controls (ANOVA: F (2, 13) =
25.38, p < 0.0001, Tukey’s post hoc compared to DMSO,
*p < 0.05).
(C) Example traces from DMSO-, sirtinol-, and resveratrol-
treated slices illustrate the robust physiological effects of
manipulating sirtuins on NAc neurons.
Error bars indicate SEM.on general locomotor responses (Figure 5D). These findings
demonstrate that sirtuin activity in the NAc is an essential regulator
of cocaine self-administration behavior and further highlight the
role played by this biochemical pathway in cocaine action.
Inhibition of class I and II HDAC’s in the NAc has been shown
to increase behavioral sensitivity to cocaine (Kumar et al., 2005;
Renthal et al., 2007), while we show here that inhibition of class
III HDAC’s (sirtuins) reduces it. Given the role of sirtuins in
regulating numerous cytosolic substrates apart from histone
proteins, it is possible that these downstream effectors are
more important contributors than histone deacetylation to sirtuin
regulation of cocaine action. Indeed, it was recently shown in
primary neuronal cultures that SIRT1 is required for normal acti-
vation of ERK, a protein well known to exert potent control over
behavioral responses to cocaine (Li et al., 2008). To determine if
ERK activation requires SIRT activity in the adult NAc, we used
ex vivo slice pharmacology to bathe NAc slices in a depolarizing
buffer (to induce ERK activation) plus either sirtinol or vehicle. We
observed a significant reduction in ERK1/2 phosphorylation in
the sirtinol-treated NAc while total ERK1/2 levels remained
unchanged (Figure 5E). These findings demonstrate that sirtinol
inhibits ERK activation in the NAc, which may be one mechanism
by which sirtinol antagonizes NAc excitability as well as cocaine
reward and self-administration.
Together, these several lines of evidence demonstrate the
ability to translate ChIP-chip data of chromatin and transcrip-
tional regulation by cocaine to identify new molecular pathways
involved in cocaine addiction.
Molecular Pathway Analysis of the ‘‘Cocaine
Transcriptome’’
To gain a more global view of the genes regulated by cocaine in the
NAc, we subjected our gene sets to Ingenuity molecular pathway
analysis software (see Figure S3). The most significantly regulatedmolecular pathways based on altered histone acetylation were
cAMP signaling, long term potentiation or depression, RXR
signaling, and neurotrophin signaling (e.g., ERK/MAP kinase and
PTEN/PI-3-kinase/Akt) pathways. Each of these pathways is
known to play integral roles in the cellular and behavioral
responses to chronic cocaine, and their enrichment in our anal-
yses supports the predictive quality of this study. Notably, chronic
cocaine also regulated several glutamate receptors and down-
stream calcium signaling molecules, including subunits of
NMDA and AMPA receptors, metabotropic receptors, and
HOMER3. The upregulation of glutamate signaling is consistent
with previous reports, which demonstrate that chronic cocaine
increases the sensitivity of NAc neurons to glutamate (Kalivas,
2004). Examples of these highly regulated pathways are shown
in Figures 6A and 6B. The panels illustrate the profound and
complex effects of cocaine on second messenger- and growth
factor-regulated molecular pathways in the NAc, and how the indi-
vidual genes in these pathways are influenced by alterations in
histone acetylation or methylation. The panels also identify which
proteins in these pathways show significant DFosB or phospho-
CREBbinding at their genepromoters,again illustrating the impor-
tant influence of these transcription factors in cocaine action.
Among the molecular pathways regulated by cocaine are
several not heretofore appreciated in cocaine action. In addition
to the sirtuins discussed above, examples include protein
ubiquitination, Toll-like receptor signaling, and FGF signaling.
Indeed, protein ubiquitination signaling regulates dendritic spine
morphology and neuronal function (Pak and Sheng, 2003), and
NAC-1, a cocaine-induced gene, can shuttle the proteasome
and a ubiquitin ligase into spines in response to neural activity
(Shen et al., 2007). While NAC-1 was not regulated at the time
point used in our ChIP-chip analyses, many ubiquitin signaling
molecules were regulated in response to cocaine and, like
NAC-1, now warrant further investigation.Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc. 343
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we have gained new insight into the layers of complex regulation
that control these pathways. For most of the pathways we inves-
tigated, chronic cocaine promotes the expression of an intricate
network of activating and inhibiting molecules. This is surprising
because we know that many of these same pathways are func-
tionally upregulated several fold after chronic cocaine. For
example, in the NFkB pathway, there is increased acetylation
on the genes coding both the transcriptional activator, p50,
and its inhibitor, IkB (see Figure 6B). However, we know that
NFkB activity is upregulated in the NAc after chronic cocaine
(Ang et al., 2001; Russo et al., 2009), suggesting that the
increased acetylation on IkB may serve to limit the primary acti-
vation of p50 and its upstream activators, TNFR and TRAF1.
Similar complex regulation is seen for the dopamine-cAMP
pathway. Cocaine functionally upregulates cAMP signaling in
NAc (Carlezon et al., 2005) but simultaneously increases histone
acetylation on the genes for the Gi-coupled D3 receptor and an
inhibitor of Gi-signaling, RGS9. The NFkB and cAMP pathways
exemplify the intricate cocaine-induced regulation of intracel-
lular signaling in the NAc and thereby underscore the importance
Figure 5. Sirtuins Regulate Behavioral
Responses to Cocaine
(A) Systemic administration of the sirtuin agonist,
resveratrol (20 mg/kg i.p., dissolved in 5% hydrox-
ypropyl b-cyclodextrin vehicle), increases the
rewarding effects of cocaine (5 mg/kg) in the
conditioned place preference paradigm (*p <
0.05, n = 9–12).
(B) Intra-NAc delivery of the sirtuin antagonist, sir-
tinol (50 mM in 5% hydroxypropyl b-cyclodextrin),
decreases the rewarding effects of 10 mg/kg
cocaine (right). Data are expressed as mean ±
SEM (n = 9–12 in each group), *p < 0.05 by t test.
(C) Intra-NAc delivery of sirtinol (100 mM) in rats
that were trained to self-administer cocaine signif-
icantly reduced the number of cocaine infusions
at the threshold dose of 62 mg/infusion (*p <
0.05, n = 5–7).
(D) The sirtinol-induced decrease in cocaine
self-administration was specific to the active
(cocaine-associated) nose poke apertures, as
they behaved normally at the inactive apertures.
(E) Sirtinol significantly reduces ERK1/2 phos-
phorylation under depolarizing conditions in acute
NAc slices ex vivo (*p < 0.05, n = 4).
Error bars indicate SEM.
of genome-wide studies which permit the
parallel assessment of multiple molecular
components of each pathway.
DISCUSSION
This study provides a genome-wide
assessment of chromatin and transcrip-
tional alterations in the NAc in response
to repeated cocaine administration.
Among the many genes that show regula-
tion by cocaine are a large number reported in previous studies
to show altered mRNA or protein expression in the NAc after
chronic cocaine (see examples in Table 1). For instance, the
cocaine-induced genes that encode ARC, CART, CDK5, NFkB,
PDYN, s-opioid receptor, and Period 1 and 2 (Freeman et al.,
2001; McClung and Nestler, 2003; Yao et al., 2004; see also
Supplemental References in Supplemental Data) were shown
in the present study to exhibit increased binding of acetylated
H3 or H4, with either attenuated or unchanged methylation of
H3 at K9/K27. Genes that are known to be downregulated by
cocaine, such as the voltage-gated potassium channel Kv8.2
and the microtubule associated protein MTAP2 (Renthal et al.,
2007), were often associated with increased methylation of H3
at K9/K27 (Table 1). For each type of histone modification,
cocaine-induced increases in acetylation or methylation at
many more genes than it induced decreases (Figure 1A).
Although there are a few examples where reductions in acetyla-
tion or methylation are associated with respective changes in
gene expression, our data suggest that chronic cocaine more
commonly regulates transcription by either increasing histone
H3 or H4 acetylation (to elevate mRNA levels), or by increasing344 Neuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc.
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However, these are observations of genome-wide data and
exceptions likely exist. There is also a subset of genes which is
highly regulated at the chromatin level but show no detectible
change in steady-state mRNA expression. For example,
mRNA’s for HDAC4 and myocyte-enhancer factors 2A and 2D
(MEF2A and MEF2D) are not altered by cocaine (data not
shown), but their promoters are dramatically altered after
cocaine treatment by histone modifications and/or transcription
factor binding. These are particularly interesting examples given
the potent influence of HDAC4 (Kumar et al., 2005) and of MEF2
(Pulipparacharuvil et al., 2008) in the NAc on cocaine responses,
and may illustrate a new layer of regulation not previously appre-
ciated. Similar disconnects between gene activity and gene or
protein expression have been observed during cocaine with-
drawal (Self et al., 2004). Bdnf is a good example where hyper-
acetylation of its promoter (Kumar et al., 2005) does not correlate
with an immediate increase in steady state BDNF expression;
however, during cocaine withdrawal, levels of BDNF protein
become significantly elevated (Grimm et al., 2003). Similarly,
gene expression arrays found increased MEF2D expression in
the NAc after extinction from cocaine self-administration
(personal communication, D.W. Self). Thus, histone acetylation
at certain genes may represent a priming mechanism to facilitate
subsequent gene induction. Taken together, our study corrobo-
rates numerous established molecular targets of cocaine action
in the NAc, and demonstrates the power of ChIP-chip assays to
uncover in a comprehensive manner the genomic targets
through which cocaine induces neural and behavioral plasticity
in this critical brain reward region. A still further advance would
be to determine whether these various cocaine-induced
changes in NAc occur in neurons versus glia (Bowers and Kali-
vas, 2003).
Likewise, results of the present study provide insight into the
target genes through which DFosB and CREB contribute to the
genomic effects of cocaine. Several genes previously identified
as targets of DFosB and CREB, inferred from gene expression
array studies of mice overexpressing the transcription factors
or their dominant-negative antagonists in the NAc (McClung
and Nestler, 2003), were identified in this study. Examples
include neurogranin, Period 1, GABAA receptor subunits, and
MEF2C, to name a few. The present findings thereby indicate
that many of the DFosB and CREB target genes determined
through overexpression studies are indeed direct, physiological
targets for these transcription factors in the NAc in vivo. Although
to the best of our knowledge there have been no prior genome-
wide ChIP-chip studies for FosB or DFosB, we should note that
many of the phospho-CREB-bound genes observed here after
chronic cocaine exposure (e.g., Pdyn, c-Fos, Mef2c, Cdk5)
were also identified as CREB targets by previous CREB ChIP-
chip studies (Impey et al., 2004; Tanis et al., 2008; Zhang et al.,
2005). While it is known that CREB targets can differ between
cell types (Cha-Molstad et al., 2004; Zhang et al., 2005),
observing many of the same genes regulated by CREB from
cultured cells to brain gives us high confidence in the predictive
quality of our data.
Of all the genes in the NAc that show markers of activation or
repression after chronic cocaine, roughly 14% exhibit alteredlevels of DFosB binding and roughly 16% exhibit altered levels
of phospho-CREB binding (Figure 2A; Figure S2; Tables S8
and S11). This is interesting in that our previous DNA expression
array study found that similar fractions of genes regulated in
the NAc after 5 days of cocaine were also regulated upon
DFosB overexpression or CREB overexpression, respectively
(McClung and Nestler, 2003). The number of cocaine-regulated
genes influenced by DFosB increased to >25%, whereas
that for CREB decreased to 5%, after 4 weeks of cocaine
administration, which illustrates the importance of performing
genome-wide ChIP-chip and gene expression studies after
longer periods of cocaine exposure and different time points of
cocaine withdrawal.
As stated, the dramatic cell type differences that have been
reported for the genomic targets of a given transcription factor
between even two types of cultured cells means that an abso-
lutely crucial next step in the field is to define modes of chromatin
regulation that occur in the brain in vivo. Indeed, well beyond
identifying lists of genes that show interesting patterns of chro-
matin regulation by cocaine, results of the present study reveal
several principles by which cocaine regulates gene expression
in the NAc of behaving animals. Among the lessons revealed
are that most cocaine-regulated genes show altered acetylation
either of histone H3 or of H4, with changes at H3 predominating,
and alterations either in histone acetylation or in histone methyl-
ation, but only rarely both modifications together on the same
gene. Another striking lesson is that phospho-CREB exerts
complex transcriptional effects and can act as a transcriptional
activator or repressor in the brain in vivo. This is also true for
DFosB, which has been shown previously (Kumar et al., 2005;
McClung and Nestler, 2003; Renthal et al., 2008) and observed
in our ChIP-chip data to associate with both transcriptionally
activating and repressing histone modifications depending on
the gene promoter and conditions involved.
There have been numerous studies of cocaine regulation of
gene expression in the NAc and other brain regions by gene
expression arrays. This research has revealed large numbers of
transcripts that are altered in response to cocaine administra-
tion. The ChIP-chip studies reported here enable the coordi-
nated use of both approaches to identify a smaller set of genes
in which the field can place greater confidence as being bona
fide targets of cocaine and the key transcription factors which
mediate cocaine’s effects. Moreover, this work begins to
describe the specific mechanisms underlying these cocaine-
induced transcriptional changes and reveals fundamentally
new insight into the genome-wide patterns of chromatin regula-
tion by cocaine in the NAc. Together, this new insight has led to
the identification of a family of genes involved in cocaine action in
the NAc, the sirtuins, which, as we have shown, play an essential
role in addiction-like behavior.
We identified Sirt1 and Sirt2 from our ChIP-chip analyses of
DFosB target genes that also were regulated by histone acetyla-
tion. We then identified significant increases in both Sirt1 and
Sirt2 mRNA and protein activity in the NAc after chronic cocaine
administration. We showed further that elevated sirtuin activity in
the NAc increases the electrical excitability of NAc MSNs
and potentiates the rewarding effects of cocaine. Finally, we
demonstrated that pharmacological inhibition of sirtuinsNeuron 62, 335–348, May 14, 2009 ª2009 Elsevier Inc. 345
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as well as the motivation to self-administer the drug. Thus, sir-
tuins appear to act downstream of DFosB and may contribute
to a positive-feedback loop in which repeated drug exposure
increases levels of DFosB and sirtuins, which in turn enhances
the motivation to take additional drug. These findings raise the
possibility of using SIRT1/2 inhibitors as potential treatment
agents for cocaine addiction.
Taken together, our ChIP-chip analyses have revealed a family
of proteins involved in cocaine responses and underscore the
vast clinical potential of the many other new gene targets identi-
fied in this study for the development of more effective treat-
ments of cocaine and potentially other drug addictions.
EXPERIMENTAL PROCEDURES
Animals and Reagents
Male C57/BL/6 mice 10–12 weeks old were obtained from Jackson Laboratory
and housed on a 12 hr light-dark cycle with access to food and water ad libi-
tum. Mice were injected i.p. with cocaine (20 mg/kg, Sigma) or saline once per
day for 7 days. 24 hr after the last dose, NAc was punch dissected from mice
as described previously (Kumar et al., 2005).
Chromatin Immunoprecipitation and Microarray Analysis
ChIP was performed for acetylated histone H3 and H4, dimethyl-K9/K27 H3,
DFosB, and phospho-CREB as described previously (Kumar et al., 2005)
with minor modifications. Immunoprecipitated DNA was amplified via liga-
tion-mediated PCR and hybridized to NimbleGen mouse promoter arrays.
See Supplemental Data for detailed ChIP-chip methods. Quantitative ChIP
was performed as described above except that the immunoprecitated DNA
was directly quantified by quantitative real-time PCR.
RT-PCR
NAc punches were homogenized in Trizol (Invitrogen, Carlsbad, CA) and pro-
cessed according to the manufacturer’s instructions. Purified RNA was
reverse transcribed using Bio-Rad iScript Kit (Hercules, CA). cDNA was quan-
tified with real-time PCR using SYBR Green (Applied Biosystems, Foster City,
CA). Each reaction was run in triplicate and analyzed using the DDCt method
as described previously (Tsankova et al., 2006).
Electrophysiological and Behavioral Analyses
Detailed methods for characterizing the effect of a sirtuin inhibitor and activator
on the electrical excitability of NAc neurons and on behavioral responses to
cocaine are provided in Supplemental Experimental Procedures in Supple-
mental Data.
ACCESSION NUMBERS
ChIP-chip data have been deposited in the Gene Expression Omnibus under
the accession GSE15968.
SUPPLEMENTAL DATA
The Supplemental Data include three figures and supplemental text and can
be found with this article online at http://www.neuron.org/supplemental/
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